After an extensive international search, Dr. Robert Bell has announced that Dr. Shaf Keshavjee has been appointed UHN’s Surgeon-in-Chief. Currently, Dr. Keshavjee serves as Head of the Division of Thoracic Surgery.
Dr. Keshavjee has been an integral part of UHN’s Thoracic Surgery Division for almost two decades. He has taken on leadership roles in all facets of this specialized area of care: as a skilled surgeon and Director of the Toronto Lung Transplant Program; as a researcher and Director of the Latner Thoracic Surgery Research Laboratories. He is the current holder of the Pearson-Ginsberg Chair in Thoracic Surgery and a Senior Scientist in the McEwen Centre for Regenerative Medicine. He has attracted worldwide attention for his pioneering research to recondition and repair injured human donor lungs using a combination of gene therapy and the Toronto XVIVO Lung Perfusion System, making them suitable for transplantation into patients.
In recognizing the achievements of Dr. Keshavjee, UHN acknowledges the tireless work of Dr. Bryce Taylor who is stepping down after serving 11 years as Surgeon-in-Chief. Dr. Taylor will be remembered for building a world-leading surgical team at UHN who, under his leadership, have successfully performed a number of surgical world firsts.